JHX Stock Analysis: James Hardie Industries | NYSE
Building Materials | NYSE, USA | Market Cap: 16.638m USD | 12M Return: 66% | IE000R94NGM2 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 273M
EPS Trend: -39.3%
Qual. Beats: 0
Rev. Trend: 78.6%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
James Hardie Industries plc manufactures and sells fiber cement, fiber gypsum, and cement-bonded boards for building and construction applications across the United States, Australia, Europe, and New Zealand. The company operates within the GICS Materials sector (Construction Materials sub-industry), with a market capitalization of $14.5 billion USD. Its products primarily serve residential and commercial new construction, and repair-and-remodel markets, making its revenue closely tied to housing starts and renovation cycles.
The business is organized into four reportable segments: Siding & Trim; Deck, Rail & Accessories; Australia & New Zealand; and Europe. The Siding & Trim segment produces siding, trim, mouldings, and interior linings under the Hardie, AZEK Exteriors, and Versatex brands. The Deck, Rail & Accessories segment offers wood-alternative decking, railing, cladding, pergolas, and outdoor accessories under the TimberTech, ULTRALOX, INTEX, and StruXure brands, representing a move into higher-margin exterior living products.
The Australia & New Zealand segment sells fiber cement products for exterior cladding, wall linings, flooring, eaves, soffits, and façades, primarily under the Hardie brand. The Europe segment produces fiber gypsum and cement-bonded boards under the fermacell brand, along with fiber cement products under the Hardie brand, serving both residential and commercial markets.
Products reach end users through specialty building products distributors, lumberyards, and home improvement retailers, supplying builders merchants, remodelers, DIY stores, and professional contractors. James Hardie was founded in 1888, is headquartered in Dublin, Ireland, and trades on the NYSE under the ticker JHX (IPO date: 2000-01-03).
- US housing starts and repair/remodel demand drive Siding & Trim volume
- AZEK integration expands decking margins and market share
- Cement and freight input costs pressure consolidated gross margins
| Net Income: 145.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -3.70 > 1.0 |
| NWC/Revenue: 12.01% < 20% (prev 61.50%; Δ -49.49% < -1%) |
| CFO/TA 0.05 > 3% & CFO 726.2m > Net Income 145.7m |
| Net Debt (4.48b) to EBITDA (1.07b): 4.17 < 3 |
| Current Ratio: 1.59 > 1.5 & < 3 |
| Outstanding Shares: last quarter (584.3m) vs 12m ago 35.54% < -2% |
| Gross Margin: 35.88% > 18% (prev 38.17%; Δ -2.29% > 0.5%) |
| Asset Turnover: 53.36% > 50% (prev 55.78%; Δ -2.42% > 0%) |
| Interest Coverage Ratio: 1.84 > 6 (EBIT TTM 467.6m / Interest Expense TTM 254.8m) |
| A: 0.05 (Total Current Assets 1.76b - Total Current Liabilities 1.11b) / Total Assets 13.5b |
| B: 0.14 (Retained Earnings 1.93b / Total Assets 13.5b) |
| C: 0.05 (EBIT TTM 467.6m / Avg Total Assets 10.1b) |
| D: 0.94 (Book Value of Equity 6.54b / Total Liabilities 6.95b) |
| Altman-Z'' = 2.08 = BBB |
| DSRI: 1.06 (Receivables 499.6m/328.9m, Revenue 5.41b/3.79b) |
| GMI: 1.06 (GM 38.17% / 35.88%) |
| AQI: 3.23 (AQ_t 0.63 / AQ_t-1 0.19) |
| SGI: 1.43 (Revenue 5.41b / 3.79b) |
| TATA: -0.04 (NI 145.7m - CFO 726.2m) / TA 13.5b) |
| Beneish M = -1.29 (Cap -4..+1) = D |
As of November 16, 2026, the stock is trading at USD 27.80 with a total of 8,485,189 shares traded. Over the past week, the price has changed by -0.18%, over one month by +12.69%, over three months by -10.00% and over the past year by +65.97%.
Current recommended Stop Loss: 25.40 (which is 8.6% or 2 ATR below the current price).
James Hardie Industries has received a consensus analysts rating of 4.90. Therefore, it is recommended to buy JHX.
- StrongBuy: 9
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 34.5 | 24.1% |
P/E Trailing = 114.64
P/E Forward = 23.9808
P/S = 2.9374
P/B = 2.6201
P/EG = 1.2402
Revenue TTM = 5.41b USD
EBIT TTM = 467.6m USD
EBITDA TTM = 1.07b USD
Long Term Debt = 4.23b USD (from longTermDebt, last quarter)
Short Term Debt = 83.7m USD (from shortTermDebt, last quarter)
Debt = 4.77b USD (from shortLongTermDebtTotal, last quarter) + Leases 245.3m
Net Debt = 4.48b USD (calculated: Debt 4.77b - CCE 289.9m)
Enterprise Value = 21.1b USD (16.6b + Debt 4.77b - CCE 289.9m)
Interest Coverage Ratio = 1.84 (Ebit TTM 467.6m / Interest Expense TTM 254.8m)
EV/FCF = 59.74x (Enterprise Value 21.1b / FCF TTM 353.5m)
FCF Yield = 1.67% (FCF TTM 353.5m / Enterprise Value 21.1b)
FCF Margin = 6.53% (FCF TTM 353.5m / Revenue TTM 5.41b)
Net Margin = 2.69% (Net Income TTM 145.7m / Revenue TTM 5.41b)
Gross Margin = 35.88% ((Revenue TTM 5.41b - Cost of Revenue TTM 3.47b) / Revenue TTM)
Gross Margin QoQ = 37.21% (prev 37.28%)
Tobins Q-Ratio = 1.56 (Enterprise Value 21.1b / Total Assets 13.5b)
Interest Expense / Debt = 5.34% (Interest Expense 254.8m / Debt 4.77b)
Taxrate = 46.88% (128.6m / 274.3m)
NOPAT = 248.4m (EBIT 467.6m * (1 - 46.88%))
Current Ratio = 1.59 (Total Current Assets 1.76b / Total Current Liabilities 1.11b)
Debt / Equity = 0.73 (Debt 4.77b / totalStockholderEquity, last quarter 6.54b)
Debt / EBITDA = 4.17 (Net Debt 4.48b / EBITDA 1.07b)
Debt / FCF = 12.67 (Net Debt 4.48b / FCF TTM 353.5m)
Total Stockholder Equity = 6.42b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.44% (Net Income 145.7m / Total Assets 13.5b)
RoE = 2.27% (Net Income TTM 145.7m / Total Stockholder Equity 6.42b)
RoCE = 4.39% (EBIT 467.6m / Capital Employed (Equity 6.42b + L.T.Debt 4.23b))
RoIC = 2.04% (NOPAT 248.4m / Invested Capital 12.2b)
WACC = 8.99% (E(16.6b)/V(21.4b) * Re(10.75%) + D(4.77b)/V(21.4b) * Rd(5.34%) * (1-Tc(0.47)))
Discount Rate = 10.75% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 82.50 | Cagr: 13.48%
[DCF] Terminal Value 70.74% ; FCFF base≈383.7m ; Y1≈336.5m ; Y5≈271.9m
[DCF] Fair Price = N/A (negative equity: EV 3.95b - Net Debt 4.48b = -529.3m; debt exceeds intrinsic value)
EPS Correlation: -39.26 | EPS CAGR: -7.28% | SUE: 0.67 | # QB: 0
Revenue Correlation: 78.58 | Revenue CAGR: 10.25% | SUE: 0.32 | # QB: 0
EPS current Quarter (2026-12-31): EPS=0.25 | Chg30d=-2.16% | Revisions=-38% | Analysts=8
EPS current Year (2027-03-31): EPS=1.35 | Chg30d=-1.14% | Revisions=-38% | GrowthEPS=+23.6% | GrowthRev=+10.9%
EPS next Year (2028-03-31): EPS=1.57 | Chg30d=-2.20% | Revisions=-12% | GrowthEPS=+16.2% | GrowthRev=+5.0%
[Analyst] Revisions Ratio: -39% (up=4, down=11)